Skip to main content
Top
Published in: Clinical Rheumatology 3/2021

01-03-2021 | Vasculitis | Case Based Review

Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature

Authors: George E. Fragoulis, Gerasimos Evangelatos, Maria G. Tektonidou

Published in: Clinical Rheumatology | Issue 3/2021

Login to get access

Abstract

IgG4-related disease (IgG4-RD) can affect almost every tissue/organ. Vascular involvement in the setting of IgG4-RD is increasingly being recognized with most of the cases pertaining patients with aortitis and/or periaortitis with or without aneurysm formation. However, it is now evident that other vessels like iliac arteries, coronary arteries, carotids, and others can also be affected being often underdiagnosed. Vascular involvement is expressed as vessel wall thickening, while aneurysm formation is also occasionally seen. Although histopathological findings are the cornerstone in the diagnosis of IgG4-RD, imaging modalities like magnetic resonance imaging (MRI) and positron emission tomography (PET) are similarly important when vascular involvement occurs, helping in the mapping of the disease and in identifying other, more accessible to biopsy, affected organs. Inflammation markers like erythrocyte sedimentation rate and C-reactive protein have also been described in IgG4-RD patients with vascular involvement. Herein, we present a case of a middle-aged man with long-term high inflammation markers who eventually diagnosed with IgG4-RD after an ascending aorta aneurysm operation, while a subsequent comprehensive magnetic resonance angiography revealed also involvement of the abdominal aorta and the left subclavian and left common carotid. Moreover, we sought to review the current literature about medium- and large-vessel involvement, beyond the aorta, in patients with IgG4-RD.
Literature
5.
go back to reference Nikiphorou E, Galloway J, Fragoulis G (2020) Overview of IgG4-related aortitis and periaortitis. A decade since their first description. Autoimmun Rev (In Press) Nikiphorou E, Galloway J, Fragoulis G (2020) Overview of IgG4-related aortitis and periaortitis. A decade since their first description. Autoimmun Rev (In Press)
17.
go back to reference Mizushima I, Kasashima S, Fujinaga Y, Notohara K, Saeki T, Zen Y, Inoue D, Yamamoto M, Kasashima F, Matsumoto Y, Amiya E, Sato Y, Yamada K, Domoto Y, Kawa S, Kawano M, Ishizaka N (2019) Clinical and pathological characteristics of IgG4-related periaortitis/periarteritis and retroperitoneal fibrosis diagnosed based on experts' diagnosis. Ann Vasc Dis 12:460–472. https://doi.org/10.3400/avd.oa.19-00085CrossRefPubMedPubMedCentral Mizushima I, Kasashima S, Fujinaga Y, Notohara K, Saeki T, Zen Y, Inoue D, Yamamoto M, Kasashima F, Matsumoto Y, Amiya E, Sato Y, Yamada K, Domoto Y, Kawa S, Kawano M, Ishizaka N (2019) Clinical and pathological characteristics of IgG4-related periaortitis/periarteritis and retroperitoneal fibrosis diagnosed based on experts' diagnosis. Ann Vasc Dis 12:460–472. https://​doi.​org/​10.​3400/​avd.​oa.​19-00085CrossRefPubMedPubMedCentral
18.
go back to reference Yabusaki S, Oyama-Manabe N, Manabe O, Hirata K, Kato F, Miyamoto N, Matsuno Y, Kudo K, Tamaki N, Shirato H (2017) Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography. EJNMMI Res 7:20. https://doi.org/10.1186/s13550-017-0268-1CrossRefPubMedPubMedCentral Yabusaki S, Oyama-Manabe N, Manabe O, Hirata K, Kato F, Miyamoto N, Matsuno Y, Kudo K, Tamaki N, Shirato H (2017) Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography. EJNMMI Res 7:20. https://​doi.​org/​10.​1186/​s13550-017-0268-1CrossRefPubMedPubMedCentral
30.
32.
go back to reference Fragoulis G, Evangelatos G (2020) IgG4-related disease: is it all the same? Rheumatology (Oxford) (In Press) Fragoulis G, Evangelatos G (2020) IgG4-related disease: is it all the same? Rheumatology (Oxford) (In Press)
37.
go back to reference Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Lohr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH, Second International Symposium on Ig GRD (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688–1699. https://doi.org/10.1002/art.39132CrossRefPubMed Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Lohr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH, Second International Symposium on Ig GRD (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688–1699. https://​doi.​org/​10.​1002/​art.​39132CrossRefPubMed
38.
go back to reference Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, Takai C, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida T (2015) Clinical features of patients with IgG4-related disease complicated with perivascular lesions. Mod Rheumatol 25:105–109. https://doi.org/10.3109/14397595.2014.903596CrossRefPubMed Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, Takai C, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida T (2015) Clinical features of patients with IgG4-related disease complicated with perivascular lesions. Mod Rheumatol 25:105–109. https://​doi.​org/​10.​3109/​14397595.​2014.​903596CrossRefPubMed
39.
go back to reference Mizushima I, Inoue D, Yamamoto M, Yamada K, Saeki T, Ubara Y, Matsui S, Masaki Y, Wada T, Kasashima S, Harada K, Takahashi H, Notohara K, Nakanuma Y, Umehara H, Yamagishi M, Kawano M (2014) Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study. Arthritis Res Ther 16:R156. https://doi.org/10.1186/ar4671CrossRefPubMedPubMedCentral Mizushima I, Inoue D, Yamamoto M, Yamada K, Saeki T, Ubara Y, Matsui S, Masaki Y, Wada T, Kasashima S, Harada K, Takahashi H, Notohara K, Nakanuma Y, Umehara H, Yamagishi M, Kawano M (2014) Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study. Arthritis Res Ther 16:R156. https://​doi.​org/​10.​1186/​ar4671CrossRefPubMedPubMedCentral
Metadata
Title
Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature
Authors
George E. Fragoulis
Gerasimos Evangelatos
Maria G. Tektonidou
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 3/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05302-1

Other articles of this Issue 3/2021

Clinical Rheumatology 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.